Analysis of Adverse Events of Dasatinib and Nilotinib in Chronic Phase Chronic Myeloid Leukemia Patients Treated Outside Clinical Trials

被引：0
|
作者：
Suh, Koung Jin [1 ,2 ]
Lee, Ji Yun [2 ]
Shin, Dong-Yeop [1 ]
Koh, Youngil [1 ]
Bang, Soo-Mee [3 ]
Yoon, Sung-Soo [1 ]
Park, Seonyang [4 ]
Kim, Inho [1 ]
Lee, Jeong-Ok [2 ]
机构：
[1] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea
[2] Seoul Natl Univ Bundang Hosp, Internal Med, Seongnam, South Korea
[3] Seoul Natl Univ Bundang Hosp, Seongnam, South Korea
[4] Inje Univ, Haeundae Paik Hosp, Internal Med, Busan, South Korea
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1902.1902
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1902
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials
    Koung Jin Suh
    Ji Yun Lee
    Dong-Yeop Shin
    Youngil Koh
    Soo-Mee Bang
    Sung-Soo Yoon
    Seonyang Park
    Inho Kim
    Jeong-Ok Lee
    International Journal of Hematology, 2017, 106 : 229 - 239
  • [2] Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials
    Suh, Koung Jin
    Lee, Ji Yun
    Shin, Dong-Yeop
    Koh, Youngil
    Bang, Soo-Mee
    Yoon, Sung-Soo
    Park, Seonyang
    Kim, Inho
    Lee, Jeong-Ok
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (02) : 229 - 239
  • [3] Pleural and pulmonary events in patients treated with dasatinib for chronic myeloid leukemia in chronic phase
    Rousselot, P. H.
    Bergeron, A.
    Rea, D.
    Levy, V.
    Picard, C.
    Meignin, V.
    Tamburini, J.
    Bruzzoni, H.
    Calvo, F.
    Tazi, A.
    Rousselot, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 203 - 203
  • [4] Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib
    Hayashi, Yoshiki
    Nakamae, Hirohisa
    Katayama, Takako
    Nakane, Takahiko
    Koh, Hideo
    Nishimoto, Mitsutaka
    Nakamae, Mika
    Yoshida, Masahiro
    Bingo, Masato
    Okamura, Hiroshi
    Aimoto, Mizuki
    Manabe, Masahiro
    Yoshimura, Takuro
    Inaba, Akiko
    Nanno, Satoshi
    Hagihara, Kiyoyuki
    Nakao, Yoshitaka
    Terada, Yoshiki
    Hino, Masayuki
    BLOOD, 2011, 118 (21) : 1607 - 1607
  • [5] Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib
    Hayashi, Yoshiki
    Nakamae, Hirohisa
    Katayama, Takako
    Nakane, Takahiko
    Koh, Hideo
    Nakamae, Mika
    Hirose, Asao
    Hagihara, Kiyoyuki
    Terada, Yoshiki
    Nakao, Yoshitaka
    Hino, Masayuki
    LEUKEMIA & LYMPHOMA, 2012, 53 (06) : 1084 - 1089
  • [6] Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis
    Noriyoshi Iriyama
    Kei-Ji Sugimoto
    Eriko Sato
    Tomoiku Takaku
    Michihide Tokuhira
    Tomonori Nakazato
    Maho Ishikawa
    Hiroyuki Fujita
    Isao Fujioka
    Yuta Kimura
    Norio Asou
    Masahiro Kizaki
    Norio Komatsu
    Yoshihiro Hatta
    Tatsuya Kawaguchi
    Medical Oncology, 2018, 35
  • [7] Comparison of the Clinical Outcomes of Nilotinib and Dasatinib Therapies in Newly Diagnosed Patients in the Chronic Phase of Chronic Myeloid Leukemia: A Retrospective Analysis
    Iriyama, Noriyoshi
    Sugimoto, Kei-Ji
    Sato, Eriko
    Takaku, Tomoiku
    Tokuhira, Michihide
    Nakazato, Tomonori
    Ishikawa, Maho
    Fujita, Hiroyuki
    Kimura, Yuta
    Fujioka, Isao
    Asou, Norio
    Kizaki, Masahiro
    Komatsu, Norio
    Hatta, Yoshihiro
    Kawaguchi, Tatsuya
    BLOOD, 2018, 132
  • [8] Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis
    Iriyama, Noriyoshi
    Sugimoto, Kei-Ji
    Sato, Eriko
    Takaku, Tomoiku
    Tokuhira, Michihide
    Nakazato, Tomonori
    Ishikawa, Maho
    Fujita, Hiroyuki
    Fujioka, Isao
    Kimura, Yuta
    Asou, Norio
    Kizaki, Masahiro
    Komatsu, Norio
    Hatta, Yoshihiro
    Kawaguchi, Tatsuya
    MEDICAL ONCOLOGY, 2018, 35 (11)
  • [9] CORRELATION OF DASATINIB PHARMACOKINETICS WITH CLINICAL RESPONSE AND ADVERSE EVENTS IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA CHRONIC PHASE
    Mita, A.
    Miura, M.
    Niioka, T.
    Abumiya, M.
    Kobayasi, T.
    Takahshi, S.
    Kameoka, Y.
    Yoshioka, T.
    Takahashi, N.
    HAEMATOLOGICA, 2015, 100 : 694 - 694
  • [10] A Propensity Score Matching Analysis of Dasatinib and Nilotinib as a Frontline Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
    Takahashi, Koichi
    Kantarjian, Hagop M.
    Yang, Yulong
    Sasaki, Koji
    Jain, Preetesh
    DellaSala, Sara
    Ravandi, Farhad
    Kadia, Tapan
    Pemmaraju, Naveen
    Daver, Naval
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Cortes, Jorge E.
    CANCER, 2016, 122 (21) : 3336 - 3343
12345